Allegria Therapeutics

Switzerland
Breíl, Grisons, Switzerland

Company profile

Allegria Therapeutics company profile

Allegria Therapeutics is a biotech research company that specializes in the diagnosis and treatment of allergy and allergy and inflammatory diseases associated with mast cell dysfunction.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2023-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$8.6M
Last funding
Seed / $5.1M / 2025-12-11
Last equity funding
Seed / $5.1M
Investors
4
Lead investors
2
Founders
1
Articles
10

Founders and investors

Founders

Maria Van Dongen

Lead investors

ALK AbellóForty51 Ventures

Investors

ALK AbellóForty51 VenturesHighLight CapitalLichtsteiner Foundation